PRISMAFLEX INTERNATIONAL - Increase in Q4 total sales by +10.9% - 2024-2025 annual revenue: EUR 54.9 million, up +6.1% - ...

THE BLOCKCHAIN GROUP - The Blockchain Group announces a convertible bond issuance of - EUR 12.1M to accelerate its Bitcoin ...

Turnover (€M) 2024-2025 2023-2024 Change Change at constant exchange rates 4th quarter 83.3 80.1 +4.0% +3.8% O/w Closures ...

AMOEBA - Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.

Resolution 24 is a standing item at each Annual General Meeting of the Company to enable CCEP to give effect to Resolutions 27 and 28. Therefore, a share repurchase cannot occur unless Resolution 24 ...

KLEA HOLDING (FR0013481835 – ALKLH), a group focused on the acquisition, development, and digitalization of companies across ...

FERMENTALG - The FDA's approval of Fermentalg's natural blue dye paves the way for a new generation of bio-based products in ...

In compliance with the requirements of the Securities Act No. 41 of 2016, ZCCM Investments Holdings PLC (“ZCCM-IH PLC” or ...

DELFINGEN INDUSTRY (DELFINGEN), a global leader in cable protection solutions in very restrictive environments, is releasing ...

VusionGroup - NielsenIQ and VusionGroup Launch Strategic Alliance to Transform Physical Retail Through Advanced Data and ...

Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital ...

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 ...